Search results

351. Novel BODIPY derivatives and ruthenium complexes conjugates as photosensitizers for bacterial inactivation in the in viv…

Principal investigator: Weronika Porolnik

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

Call: PRELUDIUM 20, Panel: NZ7

352. Short- and long-term health effects of air pollution in Eastern Poland

Principal investigator: dr hab. Łukasz Kuźma

Uniwersytet Medyczny w Białymstoku

Call: OPUS 21, Panel: NZ7

353. The use of heated tobacco and the health status of young adults in Poland

Principal investigator: Małgorzata - Znyk

Uniwersytet Medyczny w Łodzi, Wydział Nauk o Zdrowiu

Call: PRELUDIUM 20, Panel: NZ7

354. Addressing the brain glioma temozolomide therapy limitations

Principal investigator: dr hab. Joanna Małgorzata Lewandowska-Łańcucka

Uniwersytet Jagielloński, Wydział Chemii

Call: OPUS 21, Panel: NZ7

355. Blocking the TNF-TNFR2 interactions as a novel approach to the ovarian carcinoma treatment

Principal investigator: prof. Sylwia Anna Rodziewicz-Motowidło

Uniwersytet Gdański, Wydział Chemii

Call: OPUS 21, Panel: NZ7

356. Synthetic epidermal growth factor receptor inhibitor conjugated with nobel metal nanoparticles as a potential drug for t…

Principal investigator: Shaoshan Mai

Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

Call: PRELUDIUM 20, Panel: NZ7

357. Thrombin binding aptamer with expanded chemical diversity as potential anticoagulant and anticancer agent

Principal investigator: dr Weronika Paulina Kotkowiak

Instytut Chemii Bioorganicznej PAN

Call: OPUS 21, Panel: NZ7

358. New antimycotic polycations - synthesis, chemical characterization, toxicity and antifungal spectrum

Principal investigator: dr Kamil Krzysztof Kamiński

Uniwersytet Jagielloński, Collegium Medicum

Call: OPUS 21, Panel: NZ7

359. First-in-class dual biased agonists of serotonin 5-HT1A and dopamine D2 receptors – an innovative approach in the search…

Principal investigator: prof. Marcin Roman Kołaczkowski

Uniwersytet Jagielloński, Collegium Medicum

Call: OPUS 21, Panel: NZ7

360. In search for molecular targets to overcome doxorubicin resistance in triple-negative breast cancer with the use of inno…

Principal investigator: Anna Karolina Pogorzelska

Narodowy Instytut Leków

Call: PRELUDIUM 20, Panel: NZ7

361. Supporting a therapy of non-healing wounds with witch hazel bark

Principal investigator: Karolina Anna Pawłowska

Warszawski Uniwersytet Medyczny

Call: PRELUDIUM 20, Panel: NZ7

362. Wood from pine family (Pinaceae) native to Poland as a potent source of pharmacologically active lignans

Principal investigator: Andrzej Patyra

Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny

Call: PRELUDIUM 20, Panel: NZ7

363. Benchmarking Human Tissue Culture Systems that Mimic the Tumor Microenvironment

Principal investigator: prof. Matthias Nees

Uniwersytet Medyczny w Lublinie

Call: OPUS 21, Panel: NZ7

364. Is "the plastic brain" a real threat? In search of neurotoxic mechanisms of plastic nanoparticles.

Principal investigator: prof. Lidia Marta Strużyńska

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Call: OPUS 21, Panel: NZ7

365. Polystyrene nanoparticles and their epigenetic and genotoxic properties in human peripheral blood mononuclear cells

Principal investigator: Kinga Malinowska

Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

Call: PRELUDIUM 20, Panel: NZ7

366. Correlations between supramolecular structure, molecular dynamics, physico-chemical stability, and solubility in neat Ac…

Principal investigator: dr Karolina Jurkiewicz

UNIWERSYTET ŚLĄSKI, Wydział Nauk Ścisłych i Technicznych

Call: OPUS 21, Panel: NZ7

367. An innovative method of treating acute liver failure using amniotic stem cells isolated from the human placenta.

Principal investigator: dr Patrycja Lukrecja Wieczorek

Śląski Uniwersytet Medyczny w Katowicach, Centrum Medycyny Doświadczalnej

Call: PRELUDIUM 20, Panel: NZ7

368. Selective inhibitors of γ-aminobutyric acid (GABA) transporter subtype 3 (GAT3) as a new pharmacological tools and a cha…

Principal investigator: dr Dawid Marcin Panek

Uniwersytet Jagielloński, Collegium Medicum

Call: OPUS 21, Panel: NZ7

369. Aging-associated, specific pathomechanisms of endothelial dysfunction in sepsis: pathway analysis and experimental thera…

Principal investigator: prof. Stefan Karol Chłopicki

Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

Call: WEAVE-UNISONO, Panel: NZ7

370. Mechanisms of interaction between phage-derived 'dark matter' and mammalian host immunity

Principal investigator: prof. Krystyna Dąbrowska

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

Call: SHENG 2, Panel: NZ7

371. Does tormentil tincture (Tormentillae tinctura) support the therapy of leaky gut syndrome?

Principal investigator: dr Aleksandra Karolina Kruk

Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny

Call: SONATINA 5, Panel: NZ7

372. Nanoplastic and silver nanoparticles as a factor modulating the activity of estrogen-dependent intracellular signaling p…

Principal investigator: dr hab. Agnieszka Maria Grzelak

Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

Call: OPUS 20, Panel: NZ7

373. Selective activation of non-nuclear Estrogen Receptor signaling with PaPE-1 as a novel therapeutic approach for sporadic…

Principal investigator: prof. Małgorzata Kajta

Instytut Farmakologii PAN

Call: OPUS 20, Panel: NZ7

374. Smart polymer delivery systems for photosensitizers to cancer cells

Principal investigator: prof. Tomasz Adam Gośliński

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

Call: PRELUDIUM BIS 2, Panel: NZ7

375. A new class of antimicrobial compounds. Design, synthesis and study of the mechanism of action.

Principal investigator: dr hab. Sylwia Anna Rodziewicz-Motowidło

Uniwersytet Gdański, Wydział Chemii

Call: PRELUDIUM BIS 2, Panel: NZ7

376. Molecular mechanism of the protective effect of swimming training on skeletal muscle atrophy and the course of amyotroph…

Principal investigator: prof. Wiesław Ziółkowski

Gdański Uniwersytet Medyczny, Wydział Nauk o Zdrowiu z Instytutem Medycyny Morskiej i Tropikalnej

Call: OPUS 20, Panel: NZ7

377. New generation teranostatic nanocarriers for detection, diagnosis andneuroprotective treatment of ischemic stroke brain …

Principal investigator: prof. Piotr Warszyński

Instytut Katalizy i Fizykochemii Powierzchni im. Jerzego Habera PAN

Call: OPUS 20, Panel: NZ7

378. The impact of UPF1 ATP mimetics on the mutant immunopeptidome

Principal investigator: dr hab. Monikaben Padariya

Uniwersytet Gdański, Międzynarodowe Centrum Badań nad Szczepionkami Przeciwnowotworowymi

Call: OPUS 20, Panel: NZ7

379. Influence of the route of administration of new psychoactive substances on their metabolic profile

Principal investigator: dr Magdalena Anna Popławska

Narodowy Instytut Leków

Call: SONATA 16, Panel: NZ7

380. Propolis and polyphenols derived from this product as potential antifungal agents

Principal investigator: dr hab. Piotr Szweda

Politechnika Gdańska

Call: OPUS 20, Panel: NZ7

381. A new approach to imaging and rapid microbiome identification in evaluation radiotherapy effects

Principal investigator: dr hab. Dorota Katarzyna Gabryś

Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach

Call: OPUS 20, Panel: NZ7

382. Enzymes of the L-methionine biosynthetic pathway as novel moleculartargets for antifungal chemotherapy

Principal investigator: dr hab. Iwona Aniela Gabriel

Politechnika Gdańska, Wydział Chemiczny

Call: OPUS 20, Panel: NZ7

383. The study on the molecular mechanisms of cytotoxic activity of new compounds ZOT5-1-Me and ZOT5-1-Et in an experimental …

Principal investigator: dr Paulina Anna Tokarz

Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

Call: SONATA 16, Panel: NZ7

384. Regulation of a plant based synergistic toxicity between triterpene saponins and ribosome-inactivating proteins

Principal investigator: prof. Adam Matkowski

Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej

Call: OPUS 20 (LAP), Panel: NZ7

385. Delivery of immuno-activators to phagocytic cells in order to obtain an anti-tumor response

Principal investigator: dr hab. Tomasz Piotr Rygiel

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Call: OPUS 20, Panel: NZ7

386. Novel dual CYP17A1 and AKR1C3 inhibitors for studying the mechanism of resistance in prostate cancer

Principal investigator: dr hab. Tomasz Marcin Wróbel

Uniwersytet Medyczny w Lublinie

Call: SONATA 16, Panel: NZ7

387. Quinoxalino-2,3-diones as potent tools for exploration of ionotropic kainate receptors

Principal investigator: dr hab. Ewa Monika Szymańska

Uniwersytet Jagielloński, Collegium Medicum

Call: OPUS 20, Panel: NZ7

388. Drug repurposing to target p53 protein family for improved therapy in the relapsed TP53 and EGFR mutated lung cancer

Principal investigator: dr hab. Alicja Elżbieta Chrzanowska

Warszawski Uniwersytet Medyczny

Call: OPUS 20, Panel: NZ7

389. Make an old drug great again – isoniazid/rifamycin-boron clusters conjugates – synthesis and antitubercular activity.

Principal investigator: dr hab. Agnieszka Bogusława Olejniczak

Instytut Biologii Medycznej PAN

Call: OPUS 20, Panel: NZ7

390. Epidemiology and rapid spread of antimicrobial resistance amongAcinetobacter spp. strains in hospital units - analysis u…

Principal investigator: dr hab. Agnieszka Chmielarczyk

Uniwersytet Jagielloński, Collegium Medicum

Call: PRELUDIUM BIS 2, Panel: NZ7

391. A novel approach based on the optimized multidrug combination for glioblastoma treatment.

Principal investigator: prof. Małgorzata Kucińska

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

Call: SONATA 16, Panel: NZ7

392. New therapies of opioid use disorder

Principal investigator: dr Wojciech Barnaba Solecki

Uniwersytet Jagielloński, Wydział Zarządzania i Komunikacji Społecznej

Call: OPUS 20, Panel: NZ7

393. Systems of polyphenols with prebiotic carriers as combinations with unknown potential of biological activity

Principal investigator: prof. Judyta Agnieszka Cielecka-Piontek

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

Call: PRELUDIUM BIS 2, Panel: NZ7

394. Prenatal exposure to glucocorticoids as a risk factor for depression - the importance of epigenetic mechanisms in the br…

Principal investigator: dr Katarzyna Elżbieta Głombik

Instytut Farmakologii PAN

Call: SONATA 16, Panel: NZ7

395. Impairment of coronary microcirculation in a mouse model of a heart failure

Principal investigator: dr Grzegorz Stanisław Kwiatkowski

Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

Call: SONATA 16, Panel: NZ7

396. Revision of current concepts of tannins impact on gastrointestinal tract homeostasis in piglets.

Principal investigator: dr hab. Jakub Patryk Piwowarski

Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny

Call: OPUS 20 (LAP), Panel: NZ7

397. Molecular profiling of novel antipsychotic drug candidates

Principal investigator: dr hab. Jan Manuel Rodriguez Parkitna

Instytut Farmakologii PAN

Call: OPUS 20, Panel: NZ7

398. Mucoadhesive delivery systems of polyphenols as an effective way to increase their health-promoting properties

Principal investigator: dr hab. Magdalena Paczkowska-Walendowska

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

Call: SONATA 16, Panel: NZ7

399. Interactions of plant extracts traditionally used in skin diseases with a human skin microbiota

Principal investigator: prof. Sebastian Granica

Warszawski Uniwersytet Medyczny

Call: PRELUDIUM BIS 2, Panel: NZ7

400. The influence of natural plant extracts obtained by supercritical extraction on the replication inhibition of the most i…

Principal investigator: prof. Grzegorz Jan Woźniakowski

Uniwersytet Mikołaja Kopernika

Call: OPUS 20, Panel: NZ7

Projects search